Press Release | Feb 3, 2026Honigman Strengthens Life Sciences Bench with Addition of Attorney Suzanne Levy Friedman in Washington DC Office

WASHINGTON - Honigman LLP continues its strategic expansion in life sciences with the addition of medical device regulatory attorney Suzanne Levy Friedman, who joins from Hogan Lovells, to its Washington DC office. Her FDA regulatory practice in medical devices and digital health expands the capabilities of the firm's Regulatory Department.

"Suzanne brings more than a decade of Big Law experience focused on U.S. Food and Drug Administration (FDA) regulation of medical devices to Honigman," said Harold Fox, Ph.D., co- leader of Honigman's Life Sciences group and managing partner of the firm's Washington DC office. "Her FDA capabilities strengthen and complement our national life sciences platform by adding this critical practice component to our national life sciences team."

Friedman's practice focuses on guiding clients in a wide range of activities across the life cycle of their products, including preparing regulatory submissions for new device clearance and approval, advising on the lawful promotion of devices and non-device software products, and evaluating post-market product modifications. Before joining the firm, Suzanne spent over a decade in BigLaw helping medical device stakeholders anticipate, manage, and resolve regulatory risk and challenges.

"Suzanne is a highly skilled medical device regulatory attorney, and we are confident that her depth of experience will be a tremendous asset as we continue to advance our sophisticated life sciences practice," said Andrea L. Hansen, partner and chair of Honigman's Regulatory Department. "Her strong insight into the FDA's evolving landscape further enhances our ability to support clients at every stage of the product life cycle."

She is highly adept at navigating the FDA's shifting landscape for software and digital health products, having advised clients through numerous shifts in the agency's policies in this space. Known for her strategic insights and collaborative approach, Friedman helps clients identify the appropriate regulatory pathway for their product and successfully bring them through FDA's process and to market. In addition, she assists clients with conducting internal investigations involving compliance matters under the Federal Food, Drug, and Cosmetic Act (FDCA), and executing on required remediation and training activities.

Friedman received her J.D. and Masters of Bioethics from the University of Pennsylvania Law School and School of Medicine. She earned her B.A. from Princeton University.

About Honigman

Honigman LLP is an Am Law 200 full-service, general business law firm with approximately 400 attorneys counseling clients on complex issues across the country in Chicago, Michigan (Ann Arbor, Bloomfield Hills, Detroit, Grand Rapids, Kalamazoo and Lansing), Washington, D.C. and Israel (operated through Honigman Law Israel). Honigman lawyers counsel clients on complex issues in more than 60 areas of law. For more information, visit www.honigman.com.

###